Literature DB >> 23942930

Use of the word "cure" in oncology.

Kenneth Miller1, Joseph H Abraham, Lori Rhodes, Rachel Roberts.   

Abstract

PURPOSE: Use of the word "cure" in cancer care reflects a balance of physician and patient optimism, realism, medico-legal concerns, and even superstition. This study surveyed a group of oncology specialists regarding the frequency and determinants of using the word cure.
METHODS: Oncology clinicians at the Dana-Farber Cancer Institute (n = 180) were invited to complete a survey regarding the word cure in cancer care. Participants completed a 19-question survey regarding how commonly their patients are cured, how often they use the word cure in their practice, and details about its use. Three case scenarios were presented to elicit participants' views.
RESULTS: Of the 117 participants (65%) who provided responses, 81% were hesitant to tell a patient that they are cured, and 63% would never tell a patient that they are cured. Only 7% felt that greater than 75% of their patients are, or will be, cured. The participating clinicians reported that only 34% of patients ask if they are cured. For 20-year survivors of testicular cancer, large-cell lymphoma, and estrogen receptor-positive breast cancer, 84%, 76%, and 48% of clinicians, respectively, believed that the patients were cured, and 35%, 43%, and 56% recommended annual oncology follow-up of the patients. Twenty-three percent of oncology clinicians believed that patients should never be discharged from the cancer center.
CONCLUSION: Oncology clinicians report that patients are hesitant to ask whether they are cured, and the clinicians are hesitant to tell patients they are cured. Annual oncology follow-up was frequently endorsed, even after 20 years in remission.

Entities:  

Mesh:

Year:  2013        PMID: 23942930      PMCID: PMC3710180          DOI: 10.1200/JOP.2012.000806

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  7 in total

1.  Cure from breast cancer, not quite yet but getting there?

Authors:  M K Singhal; V Raina
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

2.  What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up.

Authors:  Carlo Pulitanò; Federico Castillo; Luca Aldrighetti; Martin Bodingbauer; Rowan W Parks; Gianfranco Ferla; Stephen J Wigmore; O James Garden
Journal:  HPB (Oxford)       Date:  2010-05       Impact factor: 3.647

3.  Seasons of survival: reflections of a physician with cancer.

Authors:  F Mullan
Journal:  N Engl J Med       Date:  1985-07-25       Impact factor: 91.245

4.  Late recurrence from salivary gland cancer: when does "cure" mean cure?

Authors:  Allen M Chen; Joaquin Garcia; Phillip J Granchi; Jessica Johnson; David W Eisele
Journal:  Cancer       Date:  2008-01-15       Impact factor: 6.860

5.  Seasons of survivorship revisited.

Authors:  Kenneth Miller; Brian Merry; Joan Miller
Journal:  Cancer J       Date:  2008 Nov-Dec       Impact factor: 3.360

6.  Cured of breast cancer?

Authors:  H Joensuu; S Toikkanen
Journal:  J Clin Oncol       Date:  1995-01       Impact factor: 44.544

7.  Long-term survival of patients with breast cancer: a study of the curability of the disease.

Authors:  A O Langlands; S J Pocock; G R Kerr; S M Gore
Journal:  Br Med J       Date:  1979-11-17
  7 in total
  8 in total

1.  Using population-based data to evaluate the impact of adherence to endocrine therapy on survival in breast cancer through the web-application BreCanSurvPred.

Authors:  Rebeca Font; Maria Buxó; Alberto Ameijide; José Miguel Martínez; Rafael Marcos-Gragera; Marià Carulla; Montse Puigdemont; Mireia Vilardell; Sergi Civit; Gema Viñas; Josep A Espinàs; Jaume Galceran; Ángel Izquierdo; Josep M Borràs; Ramon Clèries
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

Review 2.  Immunotherapy discontinuation - how, and when? Data from melanoma as a paradigm.

Authors:  Caroline Robert; Aurelien Marabelle; Hugo Herrscher; Caroline Caramella; Pascal Rouby; Karim Fizazi; Benjamin Besse
Journal:  Nat Rev Clin Oncol       Date:  2020-07-07       Impact factor: 66.675

3.  The ethics of talking about 'HIV cure'.

Authors:  Stuart Rennie; Mark Siedner; Joseph D Tucker; Keymanthri Moodley
Journal:  BMC Med Ethics       Date:  2015-03-27       Impact factor: 2.652

4.  Functional foods and cancer on Pinterest and PubMed: myths and science.

Authors:  Graça Justo; Eloy Macchiute de Oliveira; Claudia Jurberg
Journal:  Future Sci OA       Date:  2018-08-09

Review 5.  A Review on Curability of Cancers: More Efforts for Novel Therapeutic Options Are Needed.

Authors:  Shuncong Wang; Yewei Liu; Yuanbo Feng; Jian Zhang; Johan Swinnen; Yue Li; Yicheng Ni
Journal:  Cancers (Basel)       Date:  2019-11-13       Impact factor: 6.639

Review 6.  Long-term remission in advanced stage hepatocellular carcinoma? A chance for cure?

Authors:  Matthias Pinter; Wolfgang Sieghart
Journal:  Memo       Date:  2018-08-24

7.  Clinicians' Perspectives on Cure in Adult Patients with Acute Lymphoblastic Leukemia with Minimal Residual Disease: A Delphi Study.

Authors:  Wendy Gidman; Shweta Shah; Lirong Zhang; Jan McKendrick; Ze Cong; David Cohan; Oliver Ottmann
Journal:  Adv Ther       Date:  2019-10-04       Impact factor: 3.845

8.  No Excess Mortality up to 10 Years in Early Stages of Breast Cancer in Women Adherent to Oral Endocrine Therapy: A Probabilistic Graphical Modeling Approach.

Authors:  Ramon Clèries; Maria Buxó; Mireia Vilardell; Alberto Ameijide; José Miguel Martínez; Rebeca Font; Rafael Marcos-Gragera; Montse Puigdemont; Gemma Viñas; Marià Carulla; Josep Alfons Espinàs; Jaume Galceran; Ángel Izquierdo; Josep Maria Borràs
Journal:  Int J Environ Res Public Health       Date:  2022-03-18       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.